Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint)
JMIR Research Protocols · 2025
DOI: 10.2196/79865 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Swetambri Sharma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swiss National Science Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Puducherry, 605006, India, 91 7675935408.
- Department of Pediatrics, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India.
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
- Department of Pharmacology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India.
- Department of Pediatrics, Gynecology and Obstetrics, CANSEARCH Research Platform in Pediatric Oncology and Haematology, University of Geneva, Geneva, Switzerland.
ORCID-Profile: Swetambri Sharma, Shuvadeep Ganguly, Kamali Murugadoss, Smita Kayal, Swaminathan Keerthivasagam, Archna Singh, Deepam Pushpam, Jayanthi Mathaiyan, Yvonne Gloor, Frederic Baleydier, Marc Ansari, Sameer Bakhshi, Biswajit Dubashi, Chakradhara Rao S Uppugunduri
Förderung
- Swiss National Science Foundation
Zitieren
APA
Sharma, S., Ganguly, S., Murugadoss, K., Kayal, S., Keerthivasagam, S., Ramamoorthy, J., Singh, A., Pushpam, D., Mathaiyan, J., Gloor, Y., Baleydier, F., Ansari, M., Bakhshi, S., Dubashi, B., & Uppugunduri, C. R. S. (2025). Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint). JMIR Research Protocols. https://doi.org/10.2196/79865
Vancouver
Sharma S, Ganguly S, Murugadoss K, Kayal S, Keerthivasagam S, Ramamoorthy J, et al. Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint). JMIR Research Protocols. 2025. doi:10.2196/79865
BibTeX
@article{Sharma2025,
author = {Sharma, Swetambri and Ganguly, Shuvadeep and Murugadoss, Kamali and Kayal, Smita and Keerthivasagam, Swaminathan and Ramamoorthy, Jaikumar and Singh, Archna and Pushpam, Deepam and Mathaiyan, Jayanthi and Gloor, Yvonne and Baleydier, Frederic and Ansari, Marc and Bakhshi, Sameer and Dubashi, Biswajit and Uppugunduri, Chakradhara Rao S},
title = {Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint)},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/79865}
}
EUVIMED